Haas, M., Loupy, A., Lefaucheur, C., Roufosse, C., Glotz, D., Seron, D., Nankivell, B. J., Halloran, P. F., Colvin, R. B., Akalin, E., Alachkar, N., Bagnasco, S., Bouatou, Y., Becker, J. U., Cornell, L. D., Duong van Huyen, J. P., Gibson, I. W., Kraus, E. S., Mannon, R. B., Naesens, M., Nickeleit, V., Nickerson, P., Segev, D. L., Singh, H. K., Stegall, M., Randhawa, P., Racusen, L., Solez, K., & Mengel, M. (2018). the Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials. American journal of transplantation, 18(2), 293–307. http://access.bl.uk/ark:/81055/vdc_100056955875.0x00000f